Chest ACCP Education Calendar
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Phan, S. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Phan, S. H.
(Chest. 2002;122:286S-289S.)
© 2002 American College of Chest Physicians

The Myofibroblast in Pulmonary Fibrosis*

Sem H. Phan, PhD, MD

* From the Department of Pathology, University of Michigan, Ann Arbor, MI.

Correspondence to: Sem H. Phan, PhD, MD, Department of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109-0602; e-mail: shphan{at}umich.edu

The pathogenesis of pulmonary fibrosis remains incompletely understood. Studies of associated inflammation have led to the discovery of a number of cytokines and chemokines that are found to be important either directly or indirectly for the fibrotic process. However, the importance of inflammation in pulmonary fibrosis is unclear, and at the time of diagnosis the inflammatory component is variable and usually not responsive to anti-inflammatory therapeutic agents. Patients usually exhibit evidence of active fibrosis with increased numbers of activated fibroblasts, many of which have the phenotypic characteristics of myofibroblasts. At these sites, increased amounts of extracellular matrix deposition are evident with effacement of the normal alveolar architecture. Animal model studies show the myofibroblast to be the primary source of type I collagen gene expression in active fibrotic sites. In vitro studies show differentiation of these cells from fibroblasts under the influence of certain cytokines but indicate their susceptibility to nitric oxide-mediated apoptosis. In addition to promoting myofibroblast differentiation, transforming growth factor-ß1 provides protection against apoptosis. Thus, this well-known fibrogenic cytokine is important both for the emergence of the myofibroblast and its survival against apoptotic stimuli. This is consistent with the critical importance of this cytokine in diverse models of fibrosis in various tissues. In view of these properties, the persistence or prolonged survival of the myofibroblast may be key to understanding why certain forms of lung injury may result in progressive disease, terminating in end-stage disease.

Key Words: apoptosis • collagen • fibroblasts • myofibroblasts • telomerase • transforming growth factor-ß1




This article has been cited by other articles:


Home page
 Mol. Pharmacol.Home page
A. M. Kapoun, N. J. Gaspar, Y. Wang, D. Damm, Y.-W. Liu, G. O'Young, D. Quon, A. Lam, K. Munson, T.-T. Tran, et al.
Transforming Growth Factor-beta Receptor Type 1 (TGFbetaRI) Kinase Activity but Not p38 Activation Is Required for TGFbetaRI-Induced Myofibroblast Differentiation and Profibrotic Gene Expression
Mol. Pharmacol., August 1, 2006; 70(2): 518 - 531.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
N. Enomoto, T. Suda, M. Kato, Y. Kaida, Y. Nakamura, S. Imokawa, M. Ida, and K. Chida
Quantitative analysis of fibroblastic foci in usual interstitial pneumonia.
Chest, July 1, 2006; 130(1): 22 - 29.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
V. N. Lama, H. Harada, L. N. Badri, A. Flint, C. M. Hogaboam, A. McKenzie, F. J. Martinez, G. B. Toews, B. B. Moore, and D. J. Pinsky
Obligatory Role for Interleukin-13 in Obstructive Lesion Development in Airway Allografts
Am. J. Pathol., July 1, 2006; 169(1): 47 - 60.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
L. M. Schnapp, S. Donohoe, J. Chen, D. A. Sunde, P. M. Kelly, J. Ruzinski, T. Martin, and D. R. Goodlett
Mining the Acute Respiratory Distress Syndrome Proteome: Identification of the Insulin-Like Growth Factor (IGF)/IGF-Binding Protein-3 Pathway in Acute Lung Injury
Am. J. Pathol., July 1, 2006; 169(1): 86 - 95.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
H. A. Burgess, L. E. Daugherty, T. H. Thatcher, H. F. Lakatos, D. M. Ray, M. Redonnet, R. P. Phipps, and P. J. Sime
PPAR{gamma} agonists inhibit TGF-{beta} induced pulmonary myofibroblast differentiation and collagen production: implications for therapy of lung fibrosis
Am J Physiol Lung Cell Mol Physiol, June 1, 2005; 288(6): L1146 - L1153.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
W. E. Lawson, V. V. Polosukhin, O. Zoia, G. T. Stathopoulos, W. Han, D. Plieth, J. E. Loyd, E. G. Neilson, and T. S. Blackwell
Characterization of Fibroblast-specific Protein 1 in Pulmonary Fibrosis
Am. J. Respir. Crit. Care Med., April 15, 2005; 171(8): 899 - 907.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
K. L. Watts, E. M. Sampson, G. S. Schultz, and M. A. Spiteri
Simvastatin Inhibits Growth Factor Expression and Modulates Profibrogenic Markers in Lung Fibroblasts
Am. J. Respir. Cell Mol. Biol., April 1, 2005; 32(4): 290 - 300.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
K. Chen, Y. Wei, G. C. Sharp, and H. Braley-Mullen
Balance of proliferation and cell death between thyrocytes and myofibroblasts regulates thyroid fibrosis in granulomatous experimental autoimmune thyroiditis (G-EAT)
J. Leukoc. Biol., February 1, 2005; 77(2): 166 - 172.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
H. Zhong, L. Belardinelli, T. Maa, and D. Zeng
Synergy between A2B Adenosine Receptors and Hypoxia in Activating Human Lung Fibroblasts
Am. J. Respir. Cell Mol. Biol., January 1, 2005; 32(1): 2 - 8.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
B. Hu, Z. Wu, H. Jin, N. Hashimoto, T. Liu, and S. H. Phan
CCAAT/Enhancer-Binding Protein {beta} Isoforms and the Regulation of {alpha}-Smooth Muscle Actin Gene Expression by IL-1{beta}
J. Immunol., October 1, 2004; 173(7): 4661 - 4668.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
J. S. Torday and V. K. Rehan
Deconvoluting Lung Evolution Using Functional/Comparative Genomics
Am. J. Respir. Cell Mol. Biol., July 1, 2004; 31(1): 8 - 12.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. E. Kolodsick, G. B. Toews, C. Jakubzick, C. Hogaboam, T. A. Moore, A. McKenzie, C. A. Wilke, C. J. Chrisman, and B. B. Moore
Protection from Fluorescein Isothiocyanate-Induced Fibrosis in IL-13-Deficient, but Not IL-4-Deficient, Mice Results from Impaired Collagen Synthesis by Fibroblasts
J. Immunol., April 1, 2004; 172(7): 4068 - 4076.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
F. Huaux, T. Liu, B. McGarry, M. Ullenbruch, Z. Xing, and S. H. Phan
Eosinophils and T Lymphocytes Possess Distinct Roles in Bleomycin-Induced Lung Injury and Fibrosis
J. Immunol., November 15, 2003; 171(10): 5470 - 5481.
[Abstract] [Full Text] [PDF]

Home page
 JCBHome page
N. A. Rice and L. A. Leinwand
Skeletal myosin heavy chain function in cultured lung myofibroblasts
J. Cell Biol., October 13, 2003; 163(1): 119 - 129.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by the American College of Chest Physicians.